Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6Breast Neoplasms 3Vaginitis 1Urologic Neoplasms 1Urologic Diseases 1Sexuality 1Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Hypogonadism 1Dyspareunia 1Castration-Resistant Prostate Carcinoma 1

Interventions

olaparib 2tetracarboxyphenylporphine 1testosterone enanthate 1testosterone 17 beta-cypionate 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Testosterone Propionate 1Dexamethasone 1Cyclophosphamide 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Castration-Resistant Prostate Carcinoma × Testosterone Propionate × Clear all
NCT03516812 2025-09-29

Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer

University of Washington

Phase 2 Completed
36 enrolled 14 charts
Genitourinary

Castration-Resistant Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡